Max-Peter Seiler

Title: Max-Peter Seiler: Innovator in Cardiotonic Compounds

Introduction

Max-Peter Seiler is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardioselective compounds. His work focuses on innovative derivatives that have potential therapeutic applications.

Latest Patents

Max-Peter Seiler holds 3 patents related to 3-aminopropoxyphenyl derivatives. His latest patents include compounds that elicit highly cardioselective beta 1 adrenoceptor blockade. These compounds can be utilized as therapeutic agents due to their cardiospecific blockade and relevant cardiotonic activity. The preparation of these compounds involves 3-amino-2-oxypropylation of the respective substituted phenol.

Career Highlights

Throughout his career, Max-Peter Seiler has focused on the intersection of chemistry and pharmacology. His innovative approach has led to the development of compounds that address critical cardiovascular issues. His research has the potential to impact the pharmaceutical industry significantly.

Collaborations

Max-Peter Seiler has collaborated with notable professionals in his field, including Andre Stoll and William J Louis. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Max-Peter Seiler is a distinguished inventor whose work in cardiotonic compounds showcases his innovative spirit and dedication to improving therapeutic options in cardiovascular health. His contributions are valuable to the pharmaceutical landscape and hold promise for future advancements.